# DropMicroFluidAgents (DMFAs): Autonomous Droplet Microfluidic Research Framework Through Large Language Model Agents

arXiv: https://arxiv.org/abs/2501.14772 · HTML: https://mlsanity.com/paper/2501.14772/

## Key facts

- No citing papers in the map yet (data through 14 Oct 2026).
- Placed in Medical and scientific domain agents, one of 16 directions in LLM agents and tool use.
- Builds on 8 of its 55 references that are in the map.
- First posted on arXiv 30 Dec 2024.

## Placed in

- LLM agents and tool use / [Medical and scientific domain agents](https://mlsanity.com/agents/medical-and-scientific-domain-agents/)

## Builds on (most cited first, 8 of 8)

- [BioBERT: a pre-trained biomedical language representation model for biomedical text mining](https://mlsanity.com/paper/1901.08746/) (2019)
- [ChemCrow: Augmenting large-language models with chemistry tools](https://mlsanity.com/paper/2304.05376/) (2023)
- [Adapted Large Language Models Can Outperform Medical Experts in Clinical Text Summarization](https://mlsanity.com/paper/2309.07430/) (2023)
- [Extracting Accurate Materials Data from Research Papers with Conversational Language Models and Prompt Engineering](https://mlsanity.com/paper/2303.05352/) (2023)
- [ChatGPT Chemistry Assistant for Text Mining and Prediction of MOF Synthesis](https://mlsanity.com/paper/2306.11296/) (2023)
- [A GPT-4 Reticular Chemist for Guiding MOF Discovery](https://mlsanity.com/paper/2306.14915/) (2023)
- [Machine Learning-Assisted Discovery of Flow Reactor Designs](https://mlsanity.com/paper/2308.08841/) (2023)
- [ChatGPT in Drug Discovery: A Case Study on Anti-Cocaine Addiction Drug Development with Chatbots](https://mlsanity.com/paper/2308.06920/) (2023)

## Abstract (arXiv)

Applying Large language models (LLMs) within specific domains requires substantial adaptation to account for the unique terminologies, nuances, and context-specific challenges inherent to those areas. Here, we introduce DropMicroFluidAgents (DMFAs), an advanced language-driven framework leveraging state-of-the-art pre-trained LLMs. DMFAs employs LLM agents to perform two key functions: (1) delivering focused guidance, answers, and suggestions specific to droplet microfluidics and (2) generating machine learning models to optimise and automate the design of droplet microfluidic devices, including the creation of code-based computer-aided design (CAD) scripts to enable rapid and precise design execution. Experimental evaluations demonstrated that the integration of DMFAs with the LLAMA3.1 model yielded the highest accuracy of 76.15%, underscoring the significant performance enhancement provided by agent integration. This effect was particularly pronounced when DMFAs were paired with the GEMMA2 model, resulting in a 34.47% improvement in accuracy compared to the standalone GEMMA2 configuration. This study demonstrates the effective use of LLM agents in droplet microfluidics research as powerful tools for automating workflows, synthesising knowledge, optimising designs, and interacting with external systems. These capabilities enable their application across education and industrial support, driving greater efficiency in scientific discovery and innovation.